January 4, 2016 Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers
January 4, 2016 Host-Directed Therapies for Infectious Diseases: Current Status, Recent Progress, and Future Prospects
January 3, 2016 Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations
December 31, 2015 Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats
December 6, 2015 Development of a Patient-Reported Outcome Instrument to Assess Complex Activities of Daily Living and Interpersonal Functioning in Persons with Mild Cognitive Impairment: The Qualitative Research Phase
July 8, 2015 Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C
June 26, 2015 Patient-Centered Research To Support The Development Of The Symptoms Of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research
January 11, 2015 Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates
